Human Immunodeficiency Virus and Liver Transplantation: Our Point of View

F. Di Benedetto, S. Di Sandro, N. De Ruvo, M. Berretta, R. Montalti, G. P. Guerrini, R. Ballarin, M. G. De Blasiis, M. Spaggiari, N. Smerieri, R. M. Iemmolo, G. Guaraldi, G. E. Gerunda

Research output: Contribution to journalArticlepeer-review


Introduction: Highly active antiretroviral therapy (HAART) has been able to improve the immune system function and survival of HIV patients with a consequent increase in the number of HIV patients affected by end-stage liver disease (ESLD). Between June 2003 and October 2006, 10 HIV-positive patients underwent liver transplantations in our center. Methods: All patients were treated with HAART before transplantation; treatment was interrupted on transplantation day and was restarted once the patients' conditions stabilized. Five patients were hepatitis C virus (HCV)-positive, 3 were hepatitis B virus (HBV)-positive, and 2 were HBV-HCV coinfected. HIV viral load before transplantation was

Original languageEnglish
Pages (from-to)1965-1971
Number of pages7
JournalTransplantation Proceedings
Issue number6
Publication statusPublished - Jul 2008

ASJC Scopus subject areas

  • Surgery
  • Transplantation


Dive into the research topics of 'Human Immunodeficiency Virus and Liver Transplantation: Our Point of View'. Together they form a unique fingerprint.

Cite this